WORK Medical Technology Group Stock Triples After AI BioToken Deal — What Investors Need to Know
Shares of WORK Medical Technology Group LTD swung sharply in Tuesday’s premarket, after the U.S.-listed stock soared more than threefold on Monday. The move tracked news of an AI tie-up with Shanghai Novabioplus Biotechnology Co. The two firms aim to create medical models leveraging protein data and what WORK calls “BioTokens”—digital assets representing biological data.
